Atezolizumab
Product Specifications
UNSPSC Description
Atezolizumab (MPDL3280A) is a selective humanized monoclonal IgG1 antibody against programmed death ligand 1 (PD-L1), used for cancer research.
Target Antigen
Apoptosis; Autophagy; PD-1/PD-L1
Type
Inhibitory Antibodies
Related Pathways
Apoptosis;Autophagy;Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/Anti-PD-L1_Neutralizing_Antibody.html
Purity
99.50
Solubility
H2O
Smiles
[Atezolizumab]
References & Citations
[1]Cha E, et al. PD-L1 inhibition with MPDL3280A for solid tumors. Semin Oncol. 2015 Jun;42(3):484-7.|[2]Liu Z, et al. Targeting autophagy enhances atezolizumab-induced mitochondria-related apoptosis in osteosarcoma. Cell Death Dis. 2021;12(2):164. Published 2021 Feb 8.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P9904/Atezolizumab-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P9904/Atezolizumab-SDS-MedChemExpress.pdf
Clinical Information
Launched
CAS Number
1380723-44-3
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
DLR-UGT1A1-Hu-48T 48 Tests
Human UDP Glucuronosyltransferase 1 Family, Polypeptide A1 (UGT1A1) ELISA Kit
Ask
View Details 
